⚠️ Medical Disclaimer:GLP Metrics is an informational referral platform, not a medical provider. Content is not medical advice. Always consult a licensed doctor.Read Terms
⚖️ Clinical Comparison Guide

Compare Weight Loss &
Telehealth Medications

Use our interactive comparison engine below to review clinical efficacy, out-of-pocket costs, side effects, and dosing schedules side-by-side in United States.

VS
💉

Ozempic

Semaglutide
Approved forType 2 Diabetes (often prescribed off-label for weight loss)
Form / Dosing0.25mg to 2.0mg once weekly (subcutaneous injection)
Est. Cost$900 – $1,100 / mo
Insurance CoverageOften for T2D; rarely for off-label weight loss

✓ Pros

Very long clinical track record
Effective off-label for weight management
Once-weekly convenience

✗ Cons

Highly subject to supply shortages
Higher out-of-pocket cost without insurance
Requires self-injection
⚖️

Wegovy

Semaglutide 2.4mg
Approved forChronic Weight Management (FDA & Health Canada approved)
Form / DosingTitrated up to 2.4mg once weekly (subcutaneous injection)
Est. Cost$1,300 – $1,400 / mo
Insurance CoverageVaries; some employer plans cover weight loss specifically

✓ Pros

Specifically approved and optimized for weight loss
Higher maximum dose than Ozempic
Cardiovascular health benefits

✗ Cons

Expensive retail price
Insurance coverage is highly restricted
GI side effects common during titration

📊 Clinical Efficacy & Results

Comparing average clinical results based on double-blind trials and health agency filings.

Ozempic (15%)Up to 15% body weight reduction in clinical trials.
Wegovy (16%)15% to 17% average body weight loss in STEP clinical trials.
* For Weight Loss, numbers represent average weight loss percentage. For Hair Loss, they represent hair stabilization or regrowth success rates. For ED, numbers represent user satisfaction and overall effectiveness percentage in clinical records.

🔬 Biological Mechanism

Ozempic

GLP-1 receptor agonist. Mimics natural GLP-1 hormone to stimulate insulin secretion, slow stomach emptying, and suppress appetite.

Wegovy

High-dose GLP-1 receptor agonist. Stimulates central satiety centers in the brain to reduce hunger and caloric intake.

⏱️ Regimen & Administration

📦
Ozempic Form
Weekly Injection
📦
Wegovy Form
Weekly Injection

💡 Tip: If you struggle with needles, choose an Oral daily pill. If you value taking it once per week, Injection plans offer cleaner adherence.

⚠️ Side Effect Frequency Comparisons

Percentage of patients reporting specific symptoms during clinical trials.

Nausea
20%
24%
Diarrhea
15%
18%
Constipation
12%
14%
Vomiting
8%
10%
Headache
6%
8%
* Empty value represents not tracked or less than 0.1% incidence.
✨ Smart Recommender

Find Your Ideal Treatment Match

Answer two brief preferences to see which medication aligns best with your goals.

Medical Disclaimer: GLP Metrics is an informational referral platform, not a medical provider. This comparison guide is not medical advice. Always consult a licensed clinician before starting or switching any medication.

Choosing the right medication for weight loss, hair loss, or ED can be overwhelming given the number of options on the market. Between different dosing schedules, brand names like Wegovy, Ozempic, and Mounjaro, and varying insurance coverage, finding the best treatment requires looking at the actual clinical data. This side-by-side comparison guide breaks down the science, efficacy, and out-of-pocket costs to help you make an informed decision.

Clinical Efficacy: Semaglutide vs. Tirzepatide

For weight management, the two most popular classes are GLP-1 receptor agonists (such as semaglutide) and dual GIP/GLP-1 receptor agonists (such as tirzepatide). Clinical trials show a clear difference in average weight-loss percentages:

  • Semaglutide (Wegovy / Ozempic): Novo Nordisk's landmark STEP-1 clinical trial showed that adults taking a weekly 2.4mg dose of semaglutide lost an average of 14.9% of their baseline body weight over 68 weeks.
  • Tirzepatide (Mounjaro / Zepbound): Eli Lilly's SURMOUNT-1 clinical trial demonstrated that adults taking the highest dose (15mg weekly) achieved an average weight loss of 20.9% (about 52 lbs) over 72 weeks.

Because tirzepatide targets two different hunger hormones (GIP and GLP-1) rather than just GLP-1 alone, it tends to achieve a higher average metabolic response and greater fat-loss efficiency, though individual tolerance varies.

Dosing, Administration & Dosing Schedules

Most modern weight loss medications are self-administered via once-weekly subcutaneous injections. To minimize gastrointestinal side effects, all patients follow a strict titration schedule, starting at the lowest dose and increasing every 4 weeks:

Semaglutide Titration

Starts at 0.25mg/week for Month 1. Escalates to 0.5mg (Month 2), 1.0mg (Month 3), 1.7mg (Month 4), and reaches the maintenance dose of 2.4mg/week starting in Month 5.

Tirzepatide Titration

Starts at 2.5mg/week for Month 1. Escalates in 2.5mg increments every 4 weeks (5.0mg, 7.5mg, 10.0mg, 12.5mg) up to a maximum dose of 15.0mg/week based on efficacy and tolerance.

Side Effect Profile Comparison

The side effects of both GLP-1 medications are highly similar, primarily affecting the gastrointestinal system. Up to 40% of patients experience mild to moderate side effects during titration, which usually resolve as the body adapts:

  • Nausea & Vomiting: Most common during the first 1-2 days following a dose increase.
  • Constipation & Diarrhea: Caused by changes in bowel transit time. Constipation is often mitigated by increasing fiber and water intake.
  • Acid Reflux / Heartburn: Slowed gastric emptying can cause stomach acid to rise. Avoiding heavy meals before bed is highly recommended.

Out-of-Pocket Cost vs. Insurance Coverage

Out-of-pocket costs without insurance vary heavily. While US list prices sit around $1,000–$1,350 per month, compounding options run $150–$400. In Canada, federal price regulations cap brand Wegovy closer to $450–$600 CAD. For hair loss and ED, medications like finasteride, dutasteride, and tadalafil are typically much cheaper ($20–$65 per month) but are rarely covered by commercial or provincial plans since they are categorized as lifestyle treatments.

Frequently Asked Questions

🤔 Which weight loss medication is clinically most effective?

In clinical trials, tirzepatide (the active ingredient in Mounjaro and Zepbound) demonstrated the highest average weight loss. In Eli Lilly’s SURMOUNT-1 trial, patients on the highest dose (15mg) lost an average of 20.9% of their body weight over 72 weeks. Semaglutide (Wegovy) showed an average weight loss of approximately 15% over 68 weeks in Novo Nordisk’s STEP-1 trial.

🤔 Can I switch from semaglutide to tirzepatide?

Yes, switching medications is possible under doctor supervision. Many patients transition from semaglutide to tirzepatide if they plateau on weight loss or experience persistent side effects. Because the dosing scales differ, your provider will establish an appropriate starting dose, often requiring a reset or partial titration depending on your current tolerance.

🤔 What is the main difference between GLP-1 and GIP/GLP-1 medications?

GLP-1 receptor agonists (like semaglutide) mimic a single hormone that regulates satiety and slows stomach emptying. Dual GIP/GLP-1 agonists (like tirzepatide) mimic two hormones, which enhances insulin sensitivity and targets metabolic pathways in both the brain and adipose tissue, leading to higher average clinical efficacy.

Find Your Ideal Treatment Plan

Compare clinical options with a licensed medical professional online. Check your eligibility in 60 seconds and start a free consultation to find the right telehealth provider.

Check My Eligibility →View Providers & Pricing